logo
Plus   Neg
Share
Email

Delta Air Lines Guides FY20 EPS In Line - Quick Facts

Delta Air Lines (DAL) on Thursday provided an update on the company's business strategy and 2020 financial targets ahead of its annual event for the investment community later in the day. The company initiated earnings and revenue growth guidance for the full-year 2020.

For fiscal 2020, the company now projects earnings in a range of $6.75 to $7.75 per share on revenue growth of 4 to 6 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $7.06 per share on revenue growth of 3.7 percent to $48.62 billion for the year. Analysts' estimates typically exclude special items.

"In 2020, we expect to maintain our margins while delivering another year of $4 billion in free cash flow. We will continue to deploy capital to reinvest in the business and remain committed to returning 70 percent of free cash flow to our owners," said Paul Jacobson, Chief Financial Officer.

As a part of its ongoing commitment to sustainability, Delta is making all travel related to the 2019 Investor Day carbon neutral through verified carbon offset credits with The Guatemalan Conservation Coast Project.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT